NCT04793490View on ClinicalTrials.gov

Sphenopalatine Ganglion Block for Management of Post- Dural Puncture Headache in Obstetric Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

November 25, 2021

Study Completion Date

December 5, 2021

Conditions
Post-Dural Puncture Headache
Interventions
PROCEDURE

Sphenopalatine ganglion block

Patients will receive the SPGB via the transnasal approache by a cotton tipped applicator soaked in lignocaine 2% with 4 mg dexamethasone

DRUG

paracetamol

patients will receive paracetamol 1 g thrice daily intravenously

Trial Locations (1)

11591

Ain Shams University Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04793490 - Sphenopalatine Ganglion Block for Management of Post- Dural Puncture Headache in Obstetric Patients | Biotech Hunter | Biotech Hunter